| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Jodie M Burton, Saerom Youn, Abdullah Al-Ani, Fiona Costell. Patterns and utility of myelin oligodendrocyte glycoprotein (MOG) antibody testing in cerebrospinal fluid. Journal of neurology. 2024-02-17. PMID:38366070. |
myelin oligodendrocyte glycoprotein (mog) antibody-associated disease (mogad) is an idiopathic central nervous system (cns) demyelinating disease gaining recognition with wider availability of cell-based assay (cba) testing and recently published diagnostic criteria. |
2024-02-17 |
2024-02-19 |
Not clear |
| Ryan D Sorensen, Ashtyn Vogt, Noor Laylani, Mohammad Pakravan, Andrew G Le. Myelin oligodendrocyte glycoprotein (MOG) associated optic neuritis in a patient with idiopathic intracranial hypertension (IIH) and compressive optic neuropathy case report. BMC ophthalmology. vol 24. issue 1. 2024-02-13. PMID:38350984. |
myelin oligodendrocyte glycoprotein (mog) associated optic neuritis in a patient with idiopathic intracranial hypertension (iih) and compressive optic neuropathy case report. |
2024-02-13 |
2024-02-16 |
Not clear |
| Jin Hu, Xiangyu Zhou, Yikun Cao, Huili Tian, Na Li, Xiuli Cheng, Xiaoying Yang, Hongwan Dan. Role of CD4 T Cell in Relapsing-Remitting Experimental Autoimmune Encephalomyelitis. Journal of visualized experiments : JoVE. issue 203. 2024-02-05. PMID:38314770. |
to create the eae mice model, female mice were immunized with myelin oligodendrocyte glycoprotein (mog)35-55 emulsified with complete freund's adjuvant (cfa). |
2024-02-05 |
2024-02-09 |
mouse |
| Ganesha Liyanage, Benjamin P Trewin, Joseph A Lopez, Jane Andersen, Fiona Tea, Vera Merheb, Kristy Nguyen, Fiona X Z Lee, Marzena J Fabis-Pedrini, Alicia Zou, Ali Buckland, Anthony Fok, Michael H Barnett, Stephen W Reddel, Romain Marignier, Aseel El Hajj, Mastura Monif, Anneke van der Walt, Jeannette Lechner-Scott, Allan G Kermode, Tomas Kalincik, Simon A Broadley, Russell C Dale, Sudarshini Ramanathan, Fabienne Brilo. The MOG antibody non-P42 epitope is predictive of a relapsing course in MOG antibody-associated disease. Journal of neurology, neurosurgery, and psychiatry. 2024-01-30. PMID:38290838. |
myelin oligodendrocyte glycoprotein (mog) igg seropositivity is a prerequisite for mog antibody-associated disease (mogad) diagnosis. |
2024-01-30 |
2024-02-02 |
Not clear |
| Yun Yang, Chao Zhang, Chen Cao, Wenhua Su, Na Zhao, Wei Yu. Clinical Features of Patients with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and Isolated Seizure Symptoms. Neuropsychiatric disease and treatment. vol 20. 2024-01-22. PMID:38249524. |
myelin oligodendrocyte glycoprotein (mog) antibody-associated encephalitis is a new clinical phenotype of inflammatory demyelinating diseases. |
2024-01-22 |
2024-01-24 |
Not clear |
| Changhong Ren, Anna Zhou, Ji Zhou, Xiuwei Zhuo, Lifang Dai, Xiaojuan Tian, Xinying Yang, Shuai Gong, Changhong Ding, Fang Fang, Xiaotun Ren, Weihua Zhan. Encephalitis is an Important Phenotype of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Diseases: A Single-Center Cohort Study. Pediatric neurology. vol 152. 2024-01-19. PMID:38242024. |
myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) is considered a demyelinating disease of the central nervous system, but an increasing number of encephalitis cases associated with mog antibodies have been reported recently. |
2024-01-19 |
2024-01-22 |
Not clear |
| Atsuya Sawabe, Shogo Okazaki, Akira Nakamura, Ryo Goitsuka, Tomonori Kaif. The orphan G protein-coupled receptor 141 expressed in myeloid cells functions as an inflammation suppressor. Journal of leukocyte biology. 2024-01-16. PMID:38226682. |
lymphocytes enriched from gpr141-/- mice immunized with myelin oligodendrocyte glycoprotein (mog)35-55 produced high amounts of interferon-γ, interleukin (il)-17a, and il-6 compared to those from wt mice. |
2024-01-16 |
2024-01-18 |
mouse |
| Jihye Lee, Sungmoo Hong, Meejung Ahn, Jeongtae Kim, Changjong Moon, Hiroshi Matsuda, Akane Tanaka, Yoshihiro Nomura, Kyungsook Jung, Taekyun Shi. Eugenol alleviates the symptoms of experimental autoimmune encephalomyelitis in mice by suppressing inflammatory responses. International immunopharmacology. vol 128. 2024-01-12. PMID:38215654. |
we evaluated the therapeutic effects of eugenol on experimental autoimmune encephalomyelitis (eae), an established animal model of ms. eae was induced in c57bl/6 mice using the myelin oligodendrocyte glycoprotein (mog) |
2024-01-12 |
2024-01-15 |
mouse |
| Zhibin Tan, Yvonne May Fen Chia, Xiaomin Mu, You-Jiang Ta. Inherited chromosomally-integrated human herpes virus 6 confounding test results in a patient with myelitis and optic neuritis - A case report. Journal of neuroimmunology. vol 387. 2024-01-07. PMID:38184892. |
a case of the 'perfect storm' of myelin oligodendrocyte glycoprotein (mog) antibody-mediated myelitis, human herpesvirus 6 (hhv-6) reactivation, and covid-19 infection was reported in 2021. |
2024-01-07 |
2024-01-10 |
human |
| Sandip Ashok Sonar, Thoihen Heikrujam Metei, Surojit Karmakar, Amrita Mishra, Shrirang Inamdar, Nibedita Lenka, Girdhari La. Th17 cell promotes apoptosis of IL-23R Clinical immunology (Orlando, Fla.). 2024-01-07. PMID:38185267. |
in the present study, we showed that myelin oligodendrocyte glycoprotein 35-55 peptide (mog |
2024-01-07 |
2024-01-10 |
mouse |
| Andrea Kwakowsky, Bhavya Chawdhary, Antonio de Souza, Emily Meyer, Andrew H Kaye, Colin R Green, Stanley S Stylli, Helen Danesh-Meye. Tonabersat Significantly Reduces Disease Progression in an Experimental Mouse Model of Multiple Sclerosis. International journal of molecular sciences. vol 24. issue 24. 2023-12-23. PMID:38139284. |
the objective of the study was to evaluate if the cx43 hemichannel blocker, tonabersat, is effective in modulating the inflammatory response and reducing disability in the myelin oligodendrocyte glycoprotein 35-55-induced experimental autoimmune encephalomyelitis (mog |
2023-12-23 |
2023-12-25 |
mouse |
| Mathangi Janakiraman, Alexei Leliavski, Jeeva Varadarajulu, Dieter Jenne, Gurumoorthy Krishnamoorth. An engineered Fc fusion protein that targets antigen-specific T cells and autoantibodies mitigates autoimmune disease. Journal of neuroinflammation. vol 20. issue 1. 2023-12-07. PMID:38057803. |
here, we devised an approach to target both autoantigen-specific t cells and autoantibodies by producing a central nervous system (cns) autoantigen myelin oligodendrocyte glycoprotein (mog)-fc fusion protein. |
2023-12-07 |
2023-12-10 |
mouse |
| Takashi Saito, Rieko Suzuki, Noboru Imai, Masahiro Serizaw. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) Following Adenovirus Meningitis After First Delivery: Case Report and Literature Review. Cureus. vol 15. issue 11. 2023-12-07. PMID:38060760. |
myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) is a group of central nervous system (cns) demyelinating diseases caused by autoantibodies against myelin oligosaccharide protein (mog), a myelin sheath component protein, and present with a variety of symptoms, including optic neuritis, myelitis, acute disseminated encephalomyelitis (adem), brainstem encephalitis, and corticobasal encephalitis. |
2023-12-07 |
2023-12-17 |
Not clear |
| Kauser Yousuf, Hadiza Ibrahim, Mahfoud Elbashari, Mohamed E Abouelnaga, Amani Alzaab. A Case of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Peripheral Neuropathy With Positive Anti-Myelin Oligodendrocyte (MOG) Antibodies. Cureus. vol 15. issue 10. 2023-12-04. PMID:38046503. |
a case of eosinophilic granulomatosis with polyangiitis (egpa) peripheral neuropathy with positive anti-myelin oligodendrocyte (mog) antibodies. |
2023-12-04 |
2023-12-10 |
Not clear |
| Kauser Yousuf, Hadiza Ibrahim, Mahfoud Elbashari, Mohamed E Abouelnaga, Amani Alzaab. A Case of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Peripheral Neuropathy With Positive Anti-Myelin Oligodendrocyte (MOG) Antibodies. Cureus. vol 15. issue 10. 2023-12-04. PMID:38046503. |
recent research has shown an association between myelin oligodendrocyte glycoprotein (mog) antibodies and various neurologic conditions. |
2023-12-04 |
2023-12-10 |
Not clear |
| Jennifer M Loftis, Sankrith Ramani, Evan J Firsick, Rebekah Hudson, Anh Le-Cook, Kevin S Murnane, Arthur Vandenbark, Renee L Shirle. Immunotherapeutic treatment of inflammation in mice exposed to methamphetamine. Frontiers in psychiatry. vol 14. 2023-12-01. PMID:38025429. |
we have shown that partial (p)mhc class ii constructs (i.e., recombinant t-cell receptor ligand - rtl1000), comprised of the extracellular α1 and β1 domains of mhc class ii molecules linked covalently to myelin oligodendrocyte glycoprotein (mog)-35-55 peptide, can address the neuroimmune effects of methamphetamine addiction through its ability to bind to and down-regulate cd74 expression, block macrophage migration inhibitory factor (mif) signaling, and reduce levels of pro-inflammatory chemokine ligand 2 (ccl2). |
2023-12-01 |
2023-12-07 |
mouse |
| Jennifer M Loftis, Sankrith Ramani, Evan J Firsick, Rebekah Hudson, Anh Le-Cook, Kevin S Murnane, Arthur Vandenbark, Renee L Shirle. Immunotherapeutic treatment of inflammation in mice exposed to methamphetamine. Frontiers in psychiatry. vol 14. 2023-12-01. PMID:38025429. |
we have shown that partial (p)mhc class ii constructs (i.e., recombinant t-cell receptor ligand - rtl1000), comprised of the extracellular α1 and β1 domains of mhc class ii molecules linked covalently to myelin oligodendrocyte glycoprotein (mog)-35-55 peptide, can address the neuroimmune effects of methamphetamine addiction through its ability to bind to and down-regulate cd74 expression, block macrophage migration inhibitory factor (mif) signaling, and reduce levels of pro-inflammatory chemokine ligand 2 (ccl2). |
2023-11-29 |
2023-12-07 |
mouse |
| Donglei Liao, Linxiu Zhong, Lifen Yang, Fang He, Xiaolu Deng, Fei Yin, Jing Pen. Clinical and radiological features, treatment responses and prognosis in pediatric patients with co-existing anti-N-methyl-D-aspartate receptor and myelin oligodendrocyte glycoprotein antibody-associated encephalitis: A single center study. Multiple sclerosis and related disorders. vol 81. 2023-11-20. PMID:37984120. |
to characterize the clinical and radiological features, treatment responses and outcomes of children with co-existing anti-n-methyl-d-aspartate receptor(nmdar) and myelin oligodendrocyte glycoprotein(mog) antibody-associated encephalitis. |
2023-11-20 |
2023-11-29 |
Not clear |
| Mirasol Forcadela, Chiara Rocchi, Daniel San Martin, Emily L Gibbons, Daniel Wells, Mark R Woodhall, Patrick J Waters, Saif Huda, Shahd Hami. Timing of MOG-IgG Testing Is Key to 2023 MOGAD Diagnostic Criteria. Neurology(R) neuroimmunology & neuroinflammation. vol 11. issue 1. 2023-11-17. PMID:37977848. |
myelin oligodendrocyte glycoprotein (mog) antibody-associated disease (mogad) is a recently identified autoimmune demyelinating disorder of the cns affecting both adults and children. |
2023-11-17 |
2023-11-20 |
Not clear |
| Ranjithkumar Rajendran, Vinothkumar Rajendran, Gregor Böttiger, Christine Stadelmann, Kian Shirvanchi, Laureen von Au, Sudhanshu Bhushan, Natascha Wallendszus, Darja Schunin, Victor Westbrock, Gerhard Liebisch, Süleyman Ergün, Srikanth Karnati, Martin Berghof. The small molecule fibroblast growth factor receptor inhibitor infigratinib exerts anti-inflammatory effects and remyelination in a model of multiple sclerosis. British journal of pharmacology. vol 180. issue 23. 2023-11-16. PMID:37400950. |
here, we investigate the effects of infigratinib on prevention and suppression of first clinical episodes of myelin oligodendrocyte glycoprotein (mog) |
2023-11-16 |
2023-11-20 |
Not clear |